Inventor · San Diego, CA, US

Barbora Malecova

24Patents
6h-index
12Co-inventors
58Inventor score

Filing activity: Oct 4, 2018 → Jan 2, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US10881743B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 45 Active
US11110180B2 Nucleic acid-polypeptide compositions and uses thereof Chemistry; Metallurgy 16 Active
US11555190B2 Compositions and methods of treating Facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 10 Active
US11525137B2 Compositions and methods of treating Facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 9 Active
US11246941B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 7 Active
US11253607B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 7 Active
US11576980B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 5 Active
US11446387B2 Compositions and methods of treating muscle dystrophy Chemistry; Metallurgy 4 Active
US11912779B2 Compositions and methods of treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 4 Active
US11497814B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 2 Active
US11554176B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 2 Active
US11364302B1 Nucleic acid-polypeptide compositions and uses thereof Chemistry; Metallurgy 1 Active
US11707532B2 Compositions and methods of treating muscle dystrophy Chemistry; Metallurgy 1 Active
US11583591B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 1 Active
US12364769B2 Nucleic acid-polypeptide compositions and uses thereof Chemistry; Metallurgy 0 Active
US12071485B2 Compositions and methods of treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 0 Active
US11712478B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 0 Active
US12157774B2 Compositions and methods of treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 0 Active
US11872287B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 0 Active
US12104156B2 Compositions and methods of treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 0 Active
US12049629B2 Compositions and methods of treating Facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 0 Active
US12427202B2 Compositions and methods of treating muscle dystrophy Chemistry; Metallurgy 0 Active
US12263224B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 0 Active
US11999955B2 Compositions and methods of treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.